MedPath

Effect of transcutaneous electrical acupoint stimulation at Baihui (GV20) for patients with subjective cognitive decline: a clinical trial

Phase 1
Conditions
Subjective Cognitive Decline
Registration Number
ITMCTR2200006724
Lead Sponsor
Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meeting the diagnostic criteria for SCD
2. Aged between 55 and 75 years
3. Chinese is the mother tongue, education level is more than 6 years, amd Mini-mental State Examination (MMSE) score >24
4. Can answer and complete the questionnaire smoothly

Exclusion Criteria

1. History of psychiatry (eg, bipolar, schizophrenia, anxiety, and depression)
2. History of drug abuse
3. History of a positive neurological diagnosis that could lead to cognitive decline (eg, VCIND, brain tumor, Parkinson's)
4. Presence of serious disease (eg, cancer, infection)
5. Received acupuncture or TEAS treatment in the past 1 month
6. With pacemaker
7. With scars or wounds on the skin of the acupoints
8. Enrolled in other trails in the past 1 month

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mini-mental state examination, MMSE;shape trailing test A-B, STT A-B;subjective cognitive decline questionnaire, SCD-Q;auditory verbal learning test-Huashan version, AVLT-H;animal fluency test, AFT;Boston naming test, BNT;
Secondary Outcome Measures
NameTimeMethod
Hamilton anxiety scale, HAMA;functional activities questionnaire, FAQ);Hamilton depression scale, HAMD;
© Copyright 2025. All Rights Reserved by MedPath